Company / Share Buybacks
Bristol Myers Squibb Share Buybacks History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
-
FY2025
5-year range
$0 / $7.3B
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#42 of 48
Health Care
What the data says
Declined from $6.3B to $0 over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 48
▼
Key checks
Key Insights
- Peak share buybacks was recorded in FY2021.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0 | - |
| FY2024 | $0 | -100.0% |
| FY2023 | $6.3B | +306.7% |
| FY2022 | $1.5B | -78.8% |
| FY2021 | $7.3B | +372.2% |
| FY2020 | $1.5B | -37.4% |
| FY2019 | $2.5B | +968.8% |
| FY2018 | $231.0M | -90.6% |
| FY2017 | $2.5B | +968.8% |
| FY2016 | $231.0M | -46.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026